Article Details

AstraZeneca to buy CinCor Pharma for up to $1.8 billion - The Spokesman-Review

Retrieved on: 2023-01-09 18:11:11

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to buy CinCor Pharma for up to $1.8 billion - The Spokesman-Review. View article details on hiswai:

Excerpt

AstraZeneca agreed to buy U.S. biotech CinCor Pharma for as much as $1.8 billion to gain a promising new treatment for hypertension and kidney ...

Article found on: www.spokesman.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up